Nisin P is a natural nisin variant, the genetic determinants for which were previously identified 16 in the genomes of two Streptococcus species, albeit with no confirmed evidence of production. 17 Here we describe Streptococcus agalactiae DPC7040, a human fecal isolate, which exhibits 18 antimicrobial activity against a panel of gut and food isolates by virtue of producing nisin P. 19 Nisin P was purified, and its predicted structure was confirmed by nanoLC-MS/MS, with both 20 the fully modified peptide and a variant without rings B and E being identified. Additionally, 21 we compared its spectrum of inhibition and minimum inhibitory concentration (MIC) with that 22 of nisin A and its antimicrobial effect in a fecal fermentation in comparison with nisin A and 23 H. We found that its antimicrobial activity was less potent than nisin A and H, and we propose 24 a link between this reduced activity and the peptide structure. 25 26 Keywords: nisin, antimicrobial, structure-activity relationship, fecal microbiome, 27 Structurally, nisin is classified as a lantibiotic because it contains lanthionine (Lan), an unusual 36 amino acid formed by two alanine residues linked by a sulphur atom through their β-carbon 4 .
Introduction 28
Nisin is a small peptide with antimicrobial activity against a wide range of pathogenic bacteria. 29 It was originally sourced from a Lactococcus lactis subsp. lactis isolated from a dairy product 30 1 and is classified as a class I bacteriocin, as it is ribosomally synthesized and post-31 translationally modified 2 . Nisin has been studied extensively and has a wide range of 32 applications in the food industry, biomedicine, veterinary and research fields 3-6 . It is approved 33 as a food preservative by the Food and Agriculture Organization and is Generally Recognized 34 As Safe (GRAS) by the United States Food and Drug Administration 4 . 35 through the ABC transporter system NisFEG. However, the cluster for nisin H does not have 159 a nisI gene 15 and yet shows immunity to nisins P and A. A Blastp analysis was performed on 160 the NisFEG proteins from the four operons. The NisF-and NisG-determinants are similar in 161 the nisin A, P and U operons, but NshF and NshG from the nisin H cluster have a very low 162 percentage of similarity to equivalent proteins from the nisin A, P and U gene clusters (13.8%, 163 14. 1% and 15.4% to NshF and 9%, 8.9% and 9.8% to NshG, respectively) . NshE and NisE 164 showed 48.3% and 43.8% identity to NipE, while NsuE was more similar to NipE (79.8% 165 identity). 167 In general, purified nisin A was more potent and had a wider spectrum of inhibition than nisin 168 P ( Table 4 ). Nisin P inhibited all lactobacilli and staphylococci assayed, but inhibition was at 169 higher concentrations than that observed for nisin A, which was also able to inhibit the growth 170 of Listeria and enterococci. This is consistent with the spectrum of action of other nisins, that 171 are generally potent against lactobacilli and staphylococci, and, indeed, Gram positive bacteria 172 in general 23 . 173 Nisin activity in fecal fermentation 174 The analysis of total live bacteria in faecal samples after fermentation in the presence of two 175 concentrations (15 µM and 50 µM) of nisin A, P and H showed different consequences 176 depending on nisin type and treatment (Figure 9 ). There were significant differences in the total 177 numbers of live cells between the control and the treatments with nisin A, P and H, both at 8 178 and 24 h. Treatment with nisin A showed significantly less live cells compared to the controls 179 at 8 h, showing Log10 4.234 ± 0.023 and Log10 4.792 ± 0.01 at 15 µM and 50 µM respectively, 180 compared to Log10 5.22 ± 0.005 in the control. At 24 h, after single nisin A treatments, bacterial 181 regrowth was evident. The biggest impact was seen in samples which received a second nisin 182 A treatment at 8 h, which showed Log10 4.592 ± 0.022 and Log10 5.248 ± 0.01 of live cells at 183 15 µM and 50 µM at 24 h compared to Log10 5.22 ± 0.005 and Log10 5.461± 0.019 in the 184 control. Treatments with nisin P and nisin H showed higher numbers of live cells with all 185 treatments, the numbers of live cells being closer to those of total cells. 187 Nisin peptides also serve as auto-inducers of nisin production. The ability of nisin P, A and H 188 to activate the nisin A promotor, fused to a gfp reporter, was assessed and found to differ (Table   189 5). The promoter was more sensitive to nisin A (1 ng/ml -1 µg/ml) than nisin H (10 ng/ml -1 190 µg/ml) and nisin P (100 ng/ml -10 µg/ml). Higher concentrations of nisin P were required to 191 activate the promotor, but it continued to induce promoter activity at higher concentrations (10 192 µg/ml) whereas nisin A and H were capable of inducing the promoter only up to 1 µg/ml 193 concentrations of peptides. 195 This is the first report of production of nisin P, a natural variant of nisin, originally predicted 196 on the basis in silico of genomic analysis of other two streptococcal species 20, 24 . Initially, 197 genes related to nisin P production were identified by phylogenetic categorization of and LanC-encoding enzymes in Streptococcus pasteurianus, and analysis of the associated 199 lanA gene suggested the ability of this strain to produce an analogue of nisin U that was 200 designated nisin P 24 . The gene cluster was later reported in Streptococcus suis 20 . The fecal 201 isolate that was the focus of this study, S. agalactiae DPC7040, contained an intact nisin P 202 cluster and produced nisin P after initial induction with nisin A.
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203
The genome of S. agalactiae DPC7040 was compared with 993 S. agalactiae genomes publicly 204 available in the PATRIC database. This showed that S. agalactiae did not cluster 205 phylogenetically by human body isolation site. However, PCoA showed different clustering 206 between all strains of human origin and the strains of non-human animal origin based on 207 accessory gene content. No unique genome features could be associated with S. agalactiae 208 DPC7040, apart from the presence of the nisin P lantibiotic cluster, which was absent from the 209 other 12 stool isolates.
210
When nisin P activity was compared to nisin A and H, a lower inhibitory effect was observed.
211
Nisin P showed a higher MIC against a panel of food and gut isolates, and also had less effect 212 on the viability of the microbiota in a fermentation of human fecal material, despite being 213 sourced from a human gut isolate. One consideration is differences in stability, as both nisin H 214 and particularly nisin P lost a significant amount of activity after 24 h at pH 6-7. The differences 215 in bioactivity are also likely to be contributed to by structural differences between the 216 molecules. Nisin P is three amino acids shorter than nisin A at the important pore-forming C-217 terminal domain. Previously, removal of amino acids from the C-terminal region of nisin A, 218 affecting rings D and E, showed a decrease of up to 100 fold of its inhibitory activity against 219 L. lactis and 50 fold against Micrococcus luteus, suggesting that different conformations might 220 have a different outcome against different bacteria [25] [26] [27] . The N-terminal part of the nisin A 221 molecule, that includes rings A, B and C, has been shown to be responsible for the binding of 222 nisin to the membrane surface and / or its oligomerization 25 . Ring B is known for being very 223 sensitive in substitution studies and the removal of ring B in nisin A also gave a loss of activity 224 in nisin mutants 28 , so the absence of rings B and E in 50% of the nisin P peptides may 225 contribute to reduced activity.
226
Another important region involved in nisin bioactivity is the hinge region, at positions 21-23 227 29, 30 . The hinge region consists of the three amino acids (NMK in nisin A, AIK in nisin P) that 228 are responsible for reorientation after binding with lipid II to penetrate into the target cell 229 membrane 31 and importance in nisin antimicrobial activity has been established through 230 bioengineering studies [30] [31] [32] [33] . These studies suggest a preference for small, chiral amino acids in 231 that region 32 . Nisin H has an aromatic polar tyrosine instead of the non-polar methionine in 232 the second position. Nisin P has two changes in the hinge region, with an exchange of a polar 233 asparagine for a non-polar alanine, and an exchange of methionine with an isoleucine, both Cross-immunity assays indicated that nisin P was able to inhibit the growth of the nisin A and 244 nisin U producers, suggesting that their immunity systems are so different as to not provide 245 protection from the effect of nisin P. S. agalactiae DPC7040 was also very sensitive to nisin 246 A. Nisin P and nisin A inhibited the growth of the nisin U producer, S. uberis strain 42.
247
Although the impact of nisin A against this strain has been reported previously 15 , it contrasts 248 with initial reports that S. uberis strain 42 was cross-resistant to nisin A 13 . Nisin A and nisin P 249 were not able to inhibit the growth of S. hyointestinalis DPC6484, the nisin H producer, an 250 observation previously made in the case of nisin A 15 . S. hyointestinalis DPC6484 does not 251 have one of the two systems involved in lantibiotic immunity, NisI. NisI has been reported to 252 have a more crucial role in immunity than the NisFEG ABC transporter system, which was 253 considered to provide around 20% of the wildtype immunity 34-36 . However, another study 254 highlighted that nisI expression provided a very low level of immunity (1-4%) 37 . Regardless, 255 the immunity of S. hyointestinalis DPC6484 against other nisin peptides despite the low levels 256 of similarity of NshFEG to the homologues from the nisin A, P and U producers is somewhat 257 surprising.
258
From an autoinduction perspective, in addition to having a lower antimicrobial activity, nisin 259 P also required higher concentrations to activate the nisin A promoter. However, this might be 260 due to the specificity of the molecule or the receptor. Given the structural differences between 261 the nisin variants of lactococcal and streptococcal origin, it would be interesting to investigate 262 if using different nisin inducers with cognate receptors impacts on levels of induction.
263
In conclusion, the study of both bioengineered and natural variants of nisin aids the 264 understanding of structure-activity relationships of this molecule and that knowledge can be 265 applied to other lantibiotics and to the further development of more efficient antimicrobials.
266
Nature provides a nisin variation system and previously unknown nisin variants continue to be 267 discovered. The wide dissemination of the clusters encoding this molecule could be linked to 268 its ability to provide a competitive advantage and increased fitness. Future investigation of 269 nisin P modification and production in mixed communities might help to establish further 270 knowledge on whether it would be a good candidate as an antimicrobial agent in certain Bacteriocin operons were identified using BAGEL3 40 and manually curated using Artemis 41 .
302
Accession number for S. agalactiae DPC7040 is WIDP00000000. The S. agalactiae pan- Additionally, LanB and LanC were searched manually in genomes of the 12 stool isolates S. 318 agalactiae GBS10, 11 and 12 and MC625 to MC629 and MC631 to MC634.
319
Purification of nisin A, H and P 320
Nisin P production required initial induction with 500 ng/ml of nisin A, which was not included 321 in subsequent S. agalactiae DPC 7040 subcultures. Nisin P was purified from 2 l of S. Nisin P structural analysis 354 The intact peptide was analysed by LC-MS on a Synapt G2-Si mass spectrometer coupled to 355 an Acquity UPLC system (Waters, UK). Aliquots of the sample were injected onto an Acquity 356 UPLC® BEH C18 column, 1.7 µm, 1x100 mm (Waters, UK) and eluted with a gradient of 1-357 50% acetonitrile in 0.1% formic acid in 9 min and then ramped to 100% acetonitrile in 1 min 358 at a flow rate of 0.08 ml/min with a column temperature of 45°C. performed with the merged HCD and CID peak lists using Mascot 2.4.1 (Matrixscience, UK).
383
The search was performed, with a precursor tolerance of 6 ppm and a fragment tolerance of 0.6 384 Da, on a S. agalactiae protein sequence database, which included the nisin P gene cluster 385 (Uniprot, January 2018, 2,123 sequences) to which the nisin P peptide sequence had been 386 added. The enzyme was set to trypsin/P with a maximum of 2 allowed missed cleavages (MC). probabilities of 99% for proteins and 95% or 0% for peptides, as discussed in the results.
pH stability of nisin P compared to nisin H and A 392
Nisin P, A and H were resuspended at 1 µg/ml in distilled water. Duplicate samples at pHs 3, 393 5, 6, 7 and 8 were prepared for each nisin. Antimicrobial activity was tested at 24, 48 and 72 h 394 via well-diffusion assay using L. bulgaricus LMG 6901 as indicator. 396 Cross immunity assays were conducted by well diffusion assay to test the activity of the 397 purified nisin P and nisin A against natural nisin A, P, H and U producers. 100 μl of an 398 overnight inoculum of each indicator strain was added to 20 ml of melted agar media. 50 μl of 399 pure peptides at 0.20 mg/ml were added to a well pre-formed in the agar and incubated 400 overnight according to the growth requirements of the different nisin producers used as 401 indicator strains. Growth of the indicator strain in the presence of peptide was taken as 402 confirmation of immunity. Blastp analysis 45 was performed on the proteins responsible for the 403 immunity system, NisF, functioning as an ATPase, and NisE and NisG, the membrane 404 spanning domains of the transporter, of natural producers of nisin A, P, H and U. 406 The inhibitory activity of nisin P compared with nisin A against a range of indicator strains 407 was determined by well diffusion assay. 50 µl of the purified peptides at a concentration of 0.2 408 mg/ml were added to wells preformed in the indicator plates, which were incubated overnight 409 according to growth requirements of the indicator strain. Inhibitory activity was determined by 410 the presence of a zone of inhibition. 412 96-well plates (Sarstedt, UK) were pre-treated with bovine serum albumin (BSA) on the day 413 of assay. For this purpose, 0.5 g of BSA (Sigma, UK) was mixed with 2.5 ml of 20X phosphate 414 buffered saline (PBS, Sigma, UK). Water was added to the mix for a total volume of 50 ml. 415 200 µl were added to each well and the plate was incubated for 30 to 45 mins at 37 o C. After 416 this time, BSA was removed and the wells washed with 1X PBS and air dried in a sterile hood.
395
Cross-immunity assays
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Minimum inhibitory concentration (MIC) assays
417
For MICs, peptide concentrations of 4X the highest test concentration were prepared in 350 µl 418 of the growth media required for the target strain to grow, and 100 µl of this mix was added to 419 the first well of each row. 100 µl of the same media were added to each well and 2-fold serial 420 dilution was performed alongside the row. After this, 100 µl of culture inoculated with the 421 target strain was added to each well. To prepare this inoculum, an overnight culture was sub-422 cultured the day of the assay and incubated until an optical density (OD600) of 0.5 was reached.
423
The culture was diluted 1:10 and 20 µl of this added to 980 µl of media. 150 µl of this new mix 424 was added to 14.85 ml of growth media. The objective was to standardize the final inoculum 425 to 10 5 cfu/ml in 200 µl. The plate was incubated under the requirements of the target strain, 426 and MIC determined as the lowest peptide concentration where there was no growth of the 427 target strain. OD600 was measured using a Synergy HT Microplate reader (BioTek, UK).
428
MicroMatrix fermentations 429 Preparation of a fecal standard 430 A fecal standard for fermentation in a micro-Matrix was prepared following methodology Fecal standards were defrosted at 37 o C before use and prepared at 10% concentration in fecal Induction experiments were performed using L. lactis NZ9000 pNZ8150 gfp+, where gfp acts 473 as a reporter of expression from a nisin A inducible promoter 54 . An overnight culture of this 474 strain was diluted 1:100 into fresh media and incubated until the OD600 reached 0.5. Purified 475 nisin P, A and H were added to 1 ml of GM17 at a concentration of 1 mg/ml, 10 μg/ml, 1 μg/ml, 476 500, 100, 20, 10, 5, 2 and 1 ng/ml and 20 µl of the L. lactis NZ9000 pNZ8150 gfp+ were added 477 to the mix. 200 µl were transferred to black 96-well plates (Nunc TM , Thermo Fisher, UK) and 478 GFP was detected using a Synergy HT Microplate reader (BioTek, UK). The excitation filter 479 was set at 485 nm and the emission filter at 528 nm. 
